Dr. Scardino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Memorial Sloan Kettering Cancer Center
Kimmel Center for Prostate and Urologic Cancer, 353 E. 68th St
New York, NY 10065Phone+1 646-422-4329Fax+1 646-422-1095- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1979
Clinical Center at the National Institutes of HealthFellowship, Complex General Surgical Oncology, 1976
Massachusetts General HospitalResidency, Surgery, 1971 - 1973
Duke University School of MedicineClass of 1971
Certifications & Licensure
CA State Medical License 1975 - Present
NY State Medical License 1998 - 2025
NJ State Medical License 2021 - 2023
TX State Medical License 1979 - 2000
MD State Medical License 1973 - 1983- American Board of Urology Urology
Awards, Honors, & Recognition
- Ramon Guteras Award American Urological Association, 2014
- Fellow (FACS) American College of Surgeons
- Barringer Medal American Association of Genitourinary Surgeons, 2009
- Join now to see all
Clinical Trials
- Clinical and Quality of Life Outcomes After Open or Robotic-Assisted Laparoscopic Radical Prostatectomy Start of enrollment: 2005 Jul 01
- Men Undergoing Radical Prostatectomy Start of enrollment: 2004 Dec 28
- Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer Start of enrollment: 2002 May 14
- Join now to see all
Publications & Presentations
PubMed
- Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?Flores, J., Vertosick, E., Cooper, J., Benfante, N., Sjoberg, D., Vickers, A., Nelson, C., Jenkins, L., Eastham, J., Laudone, V., Scardino, P., Mulhall, J.> ;The Journal of Urology. 2024 Mar 1
- 4 citationsThe oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomy.Amy L Tin, Jonathan Fainberg, Samson Fine, Karim Touijer, James Eastham, Peter Scardino, Vincent Laudone, Andrew J Vickers, Behfar Ehdaie, Christopher D Gaffney, Ghali...> ;Cancer. 2023 Dec 1
- Predictive value of kallikrein forms and β-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy.Francesco Pellegrino, Daniel D Sjoberg, Amy L Tin, Nicole E Benfante, Alberto Briganti, Francesco Montorsi, Peter T Scardino, James A Eastham, Andrew J Vickers, Hans L...> ;World Journal of Urology. 2023 Jun 1
- Join now to see all
Journal Articles
- A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Utility of Tacrolimus (FK506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-S...John P Mulhall, Eric A Klein, Kevin Slawin, Peter T Scardino, The Journal of Sexual Medicine
Authored Content
- Tumor Copy Number Alteration Burden Is a Pan-Cancer Prognostic Factor Associated with Recurrence and DeathSeptember 2018
- Identification of Men with Low-Risk Biopsy-Confirmed Prostate Cancer as Candidates for Active Surveillance☆April 2018
- Identification of Men with Low-Risk Biopsy-Confirmed Prostate Cancer as Candidates for Active Surveillance☆April 2018
Press Mentions
Focal Therapy for Prostate Cancer: Should It Become a Standard of Care?June 24th, 2022- EDAP Hosting Key Opinion Leader Call on Focal One® and ExactVu™September 15th, 2020
20-Year Follow-up Data Are in: Prostate Cancer Prevention Works; Concerns About High-Grade Disease DismissedFebruary 1st, 2019- Join now to see all
Grant Support
- Urologic Oncology Research Training GrantNational Cancer Institute2005–2011
- Developmental Research ProgramNational Cancer Institute2006–2010
- Career Development ProgramNational Cancer Institute2006–2010
- Spore In Prostate CancerNational Cancer Institute2001–2008
- Urology Oncology Research Training GrantNational Cancer Institute1999–2003
- Antenoviral Vector Delivery Of HSK TK Gene With Gancivlovir In Prostate CancerNational Center For Research Resources1998–2001
- Markers Of Progression And MetastasesNational Cancer Institute1996–2001
- Prostate Neoplasm--Developmental ProjectsNational Cancer Institute1992–2001
- Prostate Neoplasm--Career Development ProgramNational Cancer Institute1992–2001
- Spore In Prostate CancerNational Cancer Institute1996–1997
- Specialized PGM Of Research Excellence/Prostate CancerNational Cancer Institute1992–1995
- DNA Ploidy And Molecular Markers Of Prostate CancerNational Cancer Institute1992–1995
- Transrectal Ultrasonography For Prostate CancerNational Cancer Institute1988–1992
- Chemotherapy Trials For Carcinoma Of The ProstateNational Cancer Institute1985
Professional Memberships
- Member
- Member
Hospital Affiliations
Memorial Sloan Kettering Cancer CenterNew York, New York
Houston Methodist HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
